# Inhibition of Che-1/AATF as a New Tool in Multiple Myeloma Treatment

> **NCT05858203** · — · UNKNOWN · sponsor: **Regina Elena Cancer Institute** · enrollment: 150 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** ATAC-seq and ChIP-seq

## Key facts

- **NCT ID:** NCT05858203
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-22
- **Primary completion:** 2023-03-21
- **Final completion:** 2025-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05858203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05858203, "Inhibition of Che-1/AATF as a New Tool in Multiple Myeloma Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05858203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*